Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
leukemia
Biotech
ADC Therapeutics calls time on sole clinical-stage candidate
The Zynlonta manufacturer is continuing to prune its pipeline, calling time on its sole remaining clinical-stage candidate.
James Waldron
May 14, 2025 9:55am
Kura, Kyowa hail ph. 2 win for leukemia drug, but hold back data
Feb 6, 2025 10:40am
Galecto buys leukemia drug, drops bone cancer asset in pivot
Oct 7, 2024 10:07am
Kura's leukemia drug works best when tacked onto existing combo
Jan 30, 2024 11:15am
FDA lets Curis resume enrollment for phase 1/2 leukemia study
Aug 31, 2022 7:50am
FDA lifts clinical hold on Curis' phase 1/2 lymphoma trial
Aug 18, 2022 11:23am
